Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,599 | Dovepress* | 4,198+ | 210 | 4,408 | |
| PubMed Central* | 401 | 175 | 576 | ||
| Totals | 4,599 | 385 | 4,984 | ||
| *Since 16 November 2021 | |||||
View citations on PubMed Central and Google Scholar